Tejon Ranch Co.

NYSE:TRC

Conglomerates

Industrials
$17.11 -0.32%

-$0.06 today

Market cap
$462.56M
Beta
0.59
P/E (TTM)
296.5
EPS (TTM)
$0.06
52W Low $15.31High $21.31

Volume 0.16M

Average 0.09M

TRC Research & Development

Spending on developing new products, technologies, and improvements to existing offerings.

Tejon Ranch Co.NYSE: TRC

Research & Development · Q1 FY2026 · quarter ended Mar 2026

Research & development remains negative

Q1 FY2026 research & development was $0, compared with $0 a year earlier. Trailing-twelve-month research & development was $0.

Context

  • Research & development amounted to 0.0% of revenue in FY2025, unchanged from a year earlier.
  • Research & development increased in 0 of the last 3 fiscal years.
  • FY2025 was the highest annual figure in the 4 fiscal years shown.

What to watch

Whether quarterly research & development holds near $0 or moves back toward the trailing-twelve-month quarterly average of $0.

Sources:Income StatementText generated from reported figures; not investment advice.

Latest quarterMar 2026
$0— QoQ
Last fiscal yearDec 2025
$0— YoY
LTMMar 2026
$0— YoY
Research & Development past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter———
1 year———
3-year CAGR———
5-year CAGR——
10-year CAGR——

Research & Development history

USD · from the income statement

Latest · FY2025
0 USD
Year-over-year change
—

Research & Development vs competitors

How TRC compares with its peers on the latest reported figures

  • Peers report in different currencies, so research & development is compared through growth and share of revenue rather than absolute size.
  • Research & development amounts to 0.0% of revenue for TRC, versus a peer median of 0.0%.
TRC Competitors
Research & Development for TRC and competitors
Company Period LTM YoY 3-year CAGR% of revenue
EVTLVertical Aerospace Ltd.LTM Mar 2026£106.28M GBP—+13.6%—
SWBISmith & Wesson Brands, Inc.LTM Apr 2026$10.3M USD+7.7%+10.9%2.0%
SRTAStrata Critical Medical, Inc.LTM Mar 2026$4.18M USD+25.8%-18.0%1.6%
FBYDFalcon's Beyond Global, Inc. Class A Common StockLTM Mar 2026$81K USD-71.2%-58.4%0.4%
TRCTejon Ranch Co.LTM Mar 2026$0 USD——0.0%
CODICompass DiversifiedLTM Mar 2026$0 USD——0.0%
ULHUniversal Logistics Holdings, Inc.LTM Apr 2026$0 USD——0.0%
ESEAEuroseas Ltd.LTM Mar 2026$0 USD——0.0%
ORNOrion Group Holdings, Inc.LTM Mar 2026$0 USD——0.0%
MTRXMatrix Service CompanyLTM Mar 2026$0 USD——0.0%
Peer median (excluding TRC) —+7.7%-3.6%0.0%

Competitors are the stored peer set for TRC. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Income Statement

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Revenue55.61M79.22M44.74M41.89M49.59M
Cost of Revenue46.03M55.79M38.57M39.99M43.48M
Gross Profit9.58M23.43M6.17M1.89M6.11M
Gross Margin17.2%29.6%13.8%4.5%12.3%
Research & Development00000
Selling, General & Admin9.84M9.7M011.09M0
Operating Expenses9.84M9.7M9.87M11.09M14.07M
Depreciation & Amortization4.59M4.63M4.81M4.89M6.01M
EBITDA13.76M27.83M10.39M8.55M7.17M
EBITDA Margin24.7%35.1%23.2%20.4%14.5%
Operating Income(260K)13.73M(3.7M)(9.2M)(7.95M)
Operating Margin-0.5%17.3%-8.3%-22.0%-16.0%
Interest Income0002.27M914K
Interest Expense00000
Other Income / Expenses9.42M9.47M9.29M12.86M9.11M
Income Before Tax9.16M23.2M5.59M3.66M1.16M
Pre-Tax Margin16.5%29.3%12.5%8.7%2.3%
Income Tax Expense3.82M7.39M2.32M976K1.09M
Net Income5.35M15.81M3.27M2.69M75K
Net Margin9.6%20.0%7.3%6.4%0.2%
EPS (Basic)0.200.600.120.100.00
EPS (Diluted)0.200.590.120.100.00
Weighted Avg Shares26.34M26.48M26.71M26.81M26.95M
Weighted Avg Shares (Diluted)26.41M26.65M26.71M26.82M26.95M

Tejon Ranch Co.

NYSE:TRC

Intrinsic Alpha fair value

Locked

Current Price

$17.11

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.